The Global Health Innovative Technology Fund (GHIT Fund) will support the GHIT Fund's third five-year plan "GHIT 3.0" (FY2023-FY2027) for the next five years from Wellcome Trust , a medical public interest foundation based in the United Kingdom. announced that it has secured a promise to receive funding of $ 20 million (about 2.7 billion yen).

Since its inception in 2013, the GHIT Fund has invested in new drug development and portfolio management to contribute to global health, impacting the world's most vulnerable and underserved populations. We have supported Japanese technology and innovation to combat infectious diseases such as malaria, tuberculosis and neglected tropical diseases (NTDs). By 2023, the 10th anniversary of our founding, we aim to further streamline and accelerate R&D on infectious diseases such as malaria, tuberculosis, and neglected tropical diseases (NTDs).

Click here for details